CN · Field Sheet
FIELD SHEET — SUMAC MFI-SUMAC-20261028-FS
Survey index / SUMAC

Sumac.

Rhus coriaria / Rhus typhina / Rhus chinensis / Rhus michauxii / Rhus hirta / Rhus glabra / Rhus copallinum
Sumac drupes; antioxidant, cardiometabolic and anti-inflammatory literature.
SEALED MFI-SUMAC-20261028-FS · RELEASED 2026-10-28
SHEET FINGERPRINTMFI-SUMAC-20261028-FS
269INCLUDED
1,754EXCLUDED
90DUPLICATE
80NON-TRANSFERABLE
0OUT OF CUTOFF
Survey totalsScroll ↓
2,193records surveyed
269studies
26claims graded
75observations
7,310graph nodes

Claim records

2 shown · bounded preview
RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-aa4d1b0e14269797GRADE VERY_LOW
sumac constituents — antioxidant
direction BENEFIT · dose 1 g; 200 mg/kg; 300 mg/kg · duration 8 week
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
10bound studies
Bound studies (4 shown of 10)
STU-07438153a4f9c772
ANIMAL · ANIMAL · 2023 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-0a218f92dea87b63
ANIMAL · ANIMAL · 2023 · RoB INSUFFICIENT_INFORMATION
2 endpoints
STU-5412651b83e3520d
ANIMAL · ANIMAL · 2025 · 8 week · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-8819533fc87b1b0b
ANIMAL · ANIMAL · 2022 · RoB INSUFFICIENT_INFORMATION
3 endpoints
Quantitative observations
observation 8 week · failed extraction
observation 1 g · validated
observation 300 mg/kg · validated
Opposition screen
SCREEN · 18 candidates considered · 3 bound as opposing
SYNTHESIS SYN-0fdcdb03930835 — outcome QUALITATIVE_ONLY · BENEFIT ×10 · not_assessed_quantitatively · 10 members
PROVENANCE → epmc:37764863, epmc:36601890, epmc:40067068 · PKG 2b1220e82ac460a9…
CLAIM · CLM-4366751b4aa16232GRADE VERY_LOW
sumac — glucose
direction BENEFIT · dose 3 g; 500 mg · duration 12 weeks; 6 week; 6 weeks; 8 weeks
Grade basis — weakest-link ceilings
HIGHdesign
MODERATEdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
8bound studies
Bound studies (4 shown of 8)
STU-0a312ef7857e3fe1
META_ANALYSIS · HUMAN · 2024 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-0a47b8fd0c972684
RCT · HUMAN · 2023 · 6 week · RoB SOME_CONCERNS
4 endpoints
STU-6261afd4fea0a9d8
META_ANALYSIS · HUMAN · 2021 · RoB LOW_RISK
5 endpoints
STU-6ff9bdf17881edae
META_ANALYSIS · HUMAN · 2024 · RoB INSUFFICIENT_INFORMATION
4 endpoints
Quantitative observations
observation 526 · validated
observation 225 · validated
observation p = 0.001 · validated
Opposition screen
SCREEN · 17 candidates considered · 3 bound as opposing
SYNTHESIS SYN-97ff9fe35f506c — outcome QUALITATIVE_ONLY · BENEFIT ×8 · not_assessed_quantitatively · 8 members
PROVENANCE → epmc:39316955, epmc:37189189, epmc:34334274 · PKG 2b1220e82ac460a9…
Bounded preview — representative records only. The full release ships 26 claims and 75 observations.